ESC 365 - Effects of sacubitril/valsartan on atrial function and structure as treatment response indicators in patients with heart failure with reduced ejection fraction: an observational prospective study.

HFA Premium Access

Effects of sacubitril/valsartan on atrial function and structure as treatment response indicators in patients with heart failure with reduced ejection fraction: an observational prospective study.

Session: Chronic heart failure - imaging 1

Topic: Imaging

Speaker: Doctor M. Camilli (Rome, IT)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Doctor Massimiliano Camilli

Catholic University of the Sacred Heart, Rome (Italy)

1 follower

6 more presentations in this session

Integrated catecholamine imaging in heart and lung across different cardiopulmonary disorders: a systems-based pilot analysis

Speaker: Doctor C. Borrelli (Pisa, IT)

The effect of transmitral to tissue Doppler imaging early diastolic velocity ratio on the prognosis according to the beta-blocker use in patients with acute heart failure

Speaker: Professor S. Kim (Ulsan, KR)

Myocardial work for LV function assessment in severe AS patients undergoing TAVR

Speaker: Miss A. Moya (Aalst, BE)

In patients with unexplained dyspnea and preserved left ventricular ejection fraction CPETecho is a useful tool to establish the cause of dyspnea

Speaker: Doctor L. Meems (Groningen, NL)

A machine learning derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: the HOMAGE trial

Speaker: Doctor M. Kobayashi (Tokyo, JP)

Access the full session

Chronic heart failure - imaging 1

Speakers: Doctor M. Camilli, Doctor C. Borrelli, Professor S. Kim, Miss A. Moya, Doctor L. Meems...

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources